-
Mashup Score: 6
Manyak, a world-renown expert in backcountry medicine, former NESA vice president and a Distinguished Eagle Scout, was 73.
Source: blog.scoutingmagazine.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 41Taking a final bow - 17 day(s) ago
Residents Bowl emcee Gary Faerber, MD, looks back on more than a decade of fun and challenges.
Source: www.auadailynews.orgCategories: General Medicine News, Hem/OncsTweet-
Kudos to our own @DukeUrology Chair @GaryFaerber for a decade of leading @AmerUrological Resident Bowl #AUA24 Join the fun today! https://t.co/IqDaCpRFaL
-
-
Mashup Score: 3Dr. Moul on the Sensitivity and A Novel Approach for PSMA PET - 4 month(s) ago
At the American Society of Clinical Oncology Genitourinary Cancer Symposium, Judd W. Moul, MD, a urologist at Duke Cancer Institute, offered his insights on …
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet-
Interview on the Sensitivity and A Novel Approach for PSMA PET https://t.co/cF1KSMO61N via @YouTube Appreciated the opportunity to be interviewed by GU Oncology Now at #GU24 @DukeGUCancer @DukeUrology @DukeCancer
-
-
Mashup Score: 7Complications Following Transrectal and Transperineal Prostate Biopsy: Results of the ProBE-PC Randomized Clinical Trial | Journal of Urology - 5 month(s) ago
Purpose:Transrectal prostate biopsy has come under scrutiny due to potential for postbiopsy infections and transperineal prostate biopsy is being offered as the safer alternative. However, there is a lack of randomized comparative studies. Our goal was to …
Source: www.auajournals.orgCategories: General Medicine News, Hem/OncsTweet-
RT @kjdelay1: so is transperineal prostate biopsy all hype? “more pain for no gain”? https://t.co/QpnXd0bEoY
-
-
Mashup Score: 4Application of next-generation imaging in biochemically recurrent prostate cancer - PubMed - 8 month(s) ago
Available data support the improved detection performance and selectivity of NGI modalities versus conventional imaging techniques; however, limited clinical evidence exists demonstrating the application of NGI to treatment decision-making and its impact on patient outcomes. The emergence of NGI and …
Source: pubmed.ncbi.nlm.nih.govCategories: Latest Headlines, Oncologists1Tweet-
Application of next-generation imaging in biochemically recurrent prostate cancer published in Pros Ca Pros Dis @pcan_journal https://t.co/jNHooh3fHC Special thanks to all my coauthors for this collaborative effort! @SFreedlandMD @CzerninJohannes
-
-
Mashup Score: 3Southeastern Section of the AUA, Inc. | Abstract Submissions - 10 month(s) ago
Abstract/Video/T. Leon Howard Case Submissions Welcome Guest Submission Dates System is Open Open: June 21, 2023 12:00 AM (Central Time U.S. & Canada) Closes: October 2, 2023 11:59 PM (Central Time U.S. & Canada) …
Source: abstracts.sesaua.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @SES_AUA: Get your scientific work submitted to be presented at #SESAUA24 at https://t.co/sL7Nf8lPWk
-
-
Mashup Score: 0A Multidisciplinary Team Approach to Prostate Cancer - 1 year(s) ago
A Multidisciplinary Team Approach to Prostate Cancer
Source: VuMediCategories: Hem/Oncs, Latest HeadlinesTweet-
A Multidisciplinary Team Approach to Prostate Cancer | VuMedi https://t.co/ojiYXO3Rwm via @vumedi Brief Video describing our prostate cancer multi-D Clinic --celebrating our 20th Anniversary in 2023! @DukeGUCancer @DukeUrology @DukeUroRes
-
-
Mashup Score: 0Please wait whilst we redirect you - 1 year(s) ago
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2023 Elsevier B.V. or its licensors or contributors. ScienceDirect® is a registered trademark of Elsevier B.V.ScienceDirect® is a registered trademark…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Kudos to @Kost_Morr @IUuro for great job on our latest work on secondary prostate cancer screening test PHI in AAM @DukeUrology @DukeUroRes @DukeGUCancer https://t.co/UQ6GtUEo3t
-
-
Mashup Score: 1Relugolix: Five Reasons Why the US Food and Drug Administration Should Have Exercised Restraint - PubMed - 1 year(s) ago
We highlight concerns regarding the approval of relugolix for patients with prostate cancer. These include the unsuitable comparator arm and primary endpoint in the HERO trial, as well as potential selection bias and the poor representativeness of the trial population. Dosing adherence to a daily ta …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @SbrtSean: Relugolix: Five Reasons Why the US Food and Drug Administration Should Have Exercised Restraint. https://t.co/aH9bQP7XJK
-
-
Mashup Score: 0Best Practices in the Utilization of Preventative Testing and Screening to Optimize Men’s Health - 1 year(s) ago
Experts in the management of men’s health provide their input on the best practices in preventative testing and screening measures to optimize the health of male patients.
Source: Patient Care OnlineCategories: Hem/Oncs, Latest HeadlinesTweet-
Check out this new Podcast! https://t.co/Cbcef5DFF4 https://t.co/otFIezk3xs
-
So saddened by loss: Michael Manyak, explorer, author and urologist dies at 73 https://t.co/bqUUMz2i0Y. Longtime Friend and former @GWUrology Chair